Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

NCT00189787 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

370

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma, Bronchial
Bronchial Asthma

Interventions

DRUG: tacrolimus

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]